|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
Modesitt SC, Hsu JY, Chowbina SR, Lawrence
RT and Hoehn KL: Not all fat is equal: differential gene expression
and potential therapeutic targets in subcutaneous adipose, visceral
adipose, and endometrium of obese women with and without
endometrial cancer. Int J Gycecol Cancer. 22:732–741. 2012.
View Article : Google Scholar
|
|
3
|
Santos CR and Schulze A: Lipid metabolism
in cancer. FEBS J. 279:2610–2623. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Imai S: The molecular mechanism of aging
and longevity and the function of Sir2 proteins. Nihon Ronen
Igakkai Zasshi. 38:735–739. 2001.(In Japanese).
|
|
5
|
Liu T, Liu PY and Marshall GM: The
critical role of the class III histone deacetylase SIRT1 in cancer.
Cancer Res. 69:1702–1705. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Katto J, Engel N, Abbas W, Herbein G and
Mahlknecht U: Transcription factor NFκB regulates the expression of
the histone deacetylase SIRT1. Clin Epigenetics. 5:112013.
|
|
7
|
Song NY and Surh YJ: Janus-faced role of
SIRT1 in tumorigenesis. Ann NY Acad Sci. 1271:10–19. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fang Y and Nicholl MB: Sirtuin 1 in
malignant transformation: friend or foe? Cancer Lett. 306:10–14.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shimano H: SREBPs: physiology and
pathophysiology of the SREBP family. FEBS J. 276:616–621. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Swinnen JV, Brusselmans K and Verhoeven G:
Increased lipogenesis in cancer cells: new players, novel targets.
Curr Opin Clin Nutr Metab Care. 9:358–365. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Menendez JA and Lupu R: Fatty acid
synthase and the lipogenic phenotype in cancer pathogenesis. Nat
Rev Cancer. 7:763–777. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li JN, Mahmoud MA, Han WF, Ripple M and
Pizer ES: Sterol regulatory element-binding protein-1 participates
in the regulation of fatty acid synthase expression in colorectal
neoplasia. Exp Cell Res. 261:159–165. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Swinnen JV: Increased lipogenesis in
steroid-responsive cancer cells: mechanisms of regulation, role in
cancer cell biology and perspectives on clinical applications. Verh
K Acad Geneeskd Belg. 63:321–333. 2001.PubMed/NCBI
|
|
14
|
Yang Yu, Morin PJ, Han WF, et al:
Regulation of fatty acid synthase expression in breast cancer by
sterol regulatory element binding protein-1c. Exp Cell Res.
282:132–137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yahagi N, Shimano H, Hasegawa K, et al:
Co-ordinate activation of lipogenic enzymes in hepatocellular
carcinoma. Eur J Cancer. 41:1316–1322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li W, Tai Y, Zhou J, et al: Repression of
endometrial tumor growth by targeting SREBP1 and lipogenesis. Cell
Cycle. 11:2348–2358. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nie LY, Lu QT, Li WH, et al: Sterol
regulatory element-binding protein 1 is required for ovarian tumor
growth. Oncol Rep. 30:1346–1354. 2013.PubMed/NCBI
|
|
18
|
Eberhard Y, Gronda M, Hurren R, et al:
Inhibition of SREBP1 sensitizes cells to death ligands. Oncotarget.
2:186–196. 2011.PubMed/NCBI
|
|
19
|
Huffman DM, Grizzle WE, Bamman MM, et al:
SIRT1 is significantly elevated in mouse and human prostate cancer.
Cancer Res. 67:6612–6618. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choi HN, Bae JS, Jamiyandorj U, et al:
Expression and role of SIRT1 in hepatocellular carcinoma. Oncol
Rep. 26:503–510. 2011.PubMed/NCBI
|
|
21
|
Kalle AM, Mallika A, Badiger J, Alinakhi,
Talukdar P and Sachchidanand: Inhibition of SIRT1 by a small
molecule induces apoptosis in breast cancer cells. Biochem Biophys
Res Commun. 401:13–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cha EJ, Noh SJ, Kwon KS, et al: Expression
of DBC1 and SIRT1 is associated with poor prognosis of gastric
carcinoma. Clin Cancer Res. 15:4453–4459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao G, Cui J, Zhang JG, et al: SIRT1 RNAi
knockdown induces apoptosis and senescence, inhibits invasion and
enhances chemosensitivity in pancreatic cancer cells. Gene Ther.
18:920–928. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakane K, Fujita Y, Terazawa R, et al:
Inhibition of cortactin and SIRT1 expression attenuates migration
and invasion of prostate cancer DU145 cells. Int J Urol. 19:71–79.
2012. View Article : Google Scholar
|
|
25
|
Firestein R, Blander G, Michan S, et al:
The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon
cancer growth. PLoS One. 3:e20202008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lai CC, Lin PM, Lin SF, et al: Altered
expression of SIRT gene family in head and neck squamous
cell carcinoma. Tumour Biol. 34:1847–1854. 2013.
|
|
27
|
Medes G, Thomas A and Weinhouse S:
Metabolism of neoplastic tissue. IV A study of lipid synthesis in
neoplastic tissue slices in vitro. Cancer Res. 13:27–29.
1953.PubMed/NCBI
|
|
28
|
Knight JR and Milner J: SIRT1, metabolism
and cancer. Curr Opin Oncol. 24:68–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eberlé D, Hegarty B, Bossard P, Ferré P
and Foufelle F: SREBP transcription factors: master regulators of
lipid homeostasis. Biochimie. 86:839–848. 2004.PubMed/NCBI
|
|
30
|
Bengoechea-Alonso MT, Punga T and Ericsson
J: Hyperphos-phorylation regulates the activity of SREBP1 during
mitosis. Proc Natl Acad Sci USA. 102:11681–11686. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ponugoti B, Kim DH, Xiao Z, et al: SIRT1
deacetylates and inhibits SREBP-1C activity in regulation of
hepatic lipid metabolism. J Biol Chem. 285:33959–33970. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Walker AK, Yang F, Jiang K, et al:
Conserved role of SIRT1 orthologs in fasting-dependent inhibition
of the lipid/cholesterol regulator SREBP. Genes Dev. 24:1403–1417.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Defour A, Dessalle K, Castro Perez A, et
al: Sirtuin 1 regulates SREBP-1c expression in a LXR-dependent
manner in skeletal muscle. PLoS One. 7:e434902012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deng X, Zhang W, O-Sullivan I, et al:
FoxO1 inhibits sterol regulatory element-binding protein-1c
(SREBP-1c) gene expression via transcription factors Sp1 and
SREBP-1c. J Biol Chem. 287:20132–20143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang W, Patil S, Chauhan B, et al: FoxO1
regulates multiple metabolic pathways in the liver: effects on
gluconeogenic, glycolytic, and lipogenic gene expression. J Biol
Chem. 281:10105–10117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Motta MC, Divecha N, Lemieux M, et al:
Mammalian SIRT1 represses forkhead transcription factors. Cell.
116:551–563. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang Y, Hou H, Haller EM, Nicosia SV and
Bai W: Suppression of FOXO1 activity by FHL2 through SIRT1-mediated
deacetylation. EMBO J. 24:1021–1032. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Frampton G, Ueno Y, Quinn M, et al: The
novel growth factor, progranulin, stimulates mouse cholangiocyte
proliferation via sirtuin-1-mediated inactivation of FOXO1. Am J
Physiol Gastrointest Liver Physiol. 303:G1202–G1211. 2012.
View Article : Google Scholar
|
